Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Dow
Express Scripts
Johnson and Johnson
Boehringer Ingelheim
Medtronic
Mallinckrodt

Last Updated: December 14, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for D-glucose

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the drug development status for D-glucose?

D-glucose is an investigational drug.

There have been 30 clinical trials for D-glucose. The most recent clinical trial was a Phase 2 trial, which was initiated on August 1st 2006.

The most common disease conditions in clinical trials are Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, and Carcinoma. The leading clinical trial sponsors are National Cancer Institute (NCI), University of Washington, and University of Pennsylvania.

Recent Clinical Trials for D-glucose
TitleSponsorPhase
18F-FSPG PET/CT in Diagnosing Early Lung Cancer in Patients With Lung NodulesCanary FoundationPhase 2
18F-FSPG PET/CT in Diagnosing Early Lung Cancer in Patients With Lung NodulesStanford UniversityPhase 2
Fluorine F 18 Fluorthanatrace PET/CT in Treating Participants With Primary or Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal CancerNational Cancer Institute (NCI)Phase 1

See all D-glucose clinical trials

Clinical Trial Summary for D-glucose

Top disease conditions for D-glucose
Top clinical trial sponsors for D-glucose

See all D-glucose clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
McKesson
Johnson and Johnson
McKinsey
Boehringer Ingelheim
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.